233 related articles for article (PubMed ID: 12377396)
1. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone.
Mason BJ; Goodman AM; Dixon RM; Hameed MH; Hulot T; Wesnes K; Hunter JA; Boyeson MG
Neuropsychopharmacology; 2002 Oct; 27(4):596-606. PubMed ID: 12377396
[TBL] [Abstract][Full Text] [Related]
2. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects.
Johnson BA; O'Malley SS; Ciraulo DA; Roache JD; Chambers RA; Sarid-Segal O; Couper D
J Clin Psychopharmacol; 2003 Jun; 23(3):281-93. PubMed ID: 12826990
[TBL] [Abstract][Full Text] [Related]
3. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
Mason BJ
J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
[TBL] [Abstract][Full Text] [Related]
4. Effect of the combination of naltrexone and acamprosate on alcohol intake in mice.
Kim SG; Han BD; Park JM; Kim MJ; Stromberg MF
Psychiatry Clin Neurosci; 2004 Feb; 58(1):30-6. PubMed ID: 14678454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.
Fucito LM; Park A; Gulliver SB; Mattson ME; Gueorguieva RV; O'Malley SS
Biol Psychiatry; 2012 Nov; 72(10):832-8. PubMed ID: 22541040
[TBL] [Abstract][Full Text] [Related]
7. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
Mason BJ
Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
[TBL] [Abstract][Full Text] [Related]
8. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
Rösner S; Leucht S; Lehert P; Soyka M
J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
[TBL] [Abstract][Full Text] [Related]
9. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
[TBL] [Abstract][Full Text] [Related]
10. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
Snyder JL; Bowers TG
Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
[TBL] [Abstract][Full Text] [Related]
12. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
Soyka M; Chick J
Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
[TBL] [Abstract][Full Text] [Related]
13. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
15. A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.
Burattini C; McGeehan AJ; Griffin WC; Gass JT; Kinder JR; Janak PH; Olive MF
Addict Biol; 2008 Mar; 13(1):70-9. PubMed ID: 18269381
[TBL] [Abstract][Full Text] [Related]
16. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
17. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
[TBL] [Abstract][Full Text] [Related]
18. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.
Ooteman W; Koeter MW; Verheul R; Schippers GM; van den Brink W
Eur Neuropsychopharmacol; 2007 Jul; 17(8):558-66. PubMed ID: 17379484
[TBL] [Abstract][Full Text] [Related]
19. Acamprosate: A Review of Its Use in Alcohol Dependence.
Plosker GL
Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
[TBL] [Abstract][Full Text] [Related]
20. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
Soyka M; Rösner S
Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
